IKARIAN CAPITAL, LLC – Apellis Pharmaceuticals, Inc. Transaction History
IKARIAN CAPITAL, LLC portfolio value:
$0
portfolio value
Apellis Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | call | Decrease | -100.00% | -123.2K shares | -5.57M | $68.3 | 0 |
Q3 2022 | share | Decrease | -100.00% | -41.9K shares | -1.89M | $68.3 | 0 |
Q2 2022 | call | Decrease | -29.64% | -51.9K shares | -3.32M | $45.22 | 123.2K |
Q2 2022 | share | Increase | 0.00% | 41.9K shares | 1.89M | $45.22 | 41.9K |
Q1 2022 | call | Decrease | -12.45% | -24.9K shares | -559K | $50.81 | 175.1K |
Q4 2021 | share | Decrease | -100.00% | -347.54K shares | -11.45M | $47.95 | 0 |
Q4 2021 | call | Decrease | -14.16% | -33K shares | 1.77M | $47.95 | 200K |
Q4 2021 | put | Decrease | -100.00% | -345.4K shares | -11.38M | $47.95 | 0 |
Q3 2021 | call | Decrease | -22.33% | -67K shares | -11.28M | $32.96 | 233K |
Q3 2021 | share | Increase | 0.00% | 347.54K shares | 11.45M | $32.96 | 347.54K |
Q3 2021 | put | Increase | +15.13% | 45.4K shares | -7.57M | $32.96 | 345.4K |
Q2 2021 | put | Increase | 0.00% | 300K shares | 18.96M | $63.2 | 300K |
Q2 2021 | call | Increase | 0.00% | 300K shares | 18.96M | $63.2 | 300K |
Q4 2020 | share | Decrease | -100.00% | -18.72K shares | -565K | $57.2 | 0 |
Q3 2020 | share | Increase | +780.81% | 16.6K shares | 496K | $30.17 | 18.72K |
Q2 2020 | share | Decrease | -95.92% | -50K shares | -1.32M | $32.66 | 2.12K |
Q1 2020 | call | Decrease | -100.00% | -240.3K shares | -7.35M | $26.79 | 0 |
Q1 2020 | share | Increase | +98250.94% | 52.07K shares | 1.39M | $26.79 | 52.12K |
Q1 2020 | put | Decrease | -100.00% | -286.9K shares | -8.78M | $26.79 | 0 |
Q4 2019 | put | Increase | 0.00% | 286.9K shares | 8.78M | $30.62 | 286.9K |
Q4 2019 | share | Increase | 0.00% | 53 shares | 2K | $30.62 | 53 |
Q4 2019 | call | Increase | 0.00% | 240.3K shares | 7.35M | $30.62 | 240.3K |